Valeant Pharmaceuticals announced a sweetened bid for Allergan on Friday, only two days after increasing its offer for the maker of Botox. The drug maker is now offering $72 a share in cash.
via NYT > Business Day http://ift.tt/1jBxXx3
via WordPress http://ift.tt/1o7KtZi
No comments:
Post a Comment